| 3/12/2024 | 300215000000 | LABELLED SACTUZUMAB 200 MG POWDER'S MATERIAL IS FOR CLINICAL RESEARCH PURPOSES. IT IS NOT IN THE SCOPE OF 2024/16-19 NOTIFICATION. | 1000 | UNIT | 290309 | N/A | MERCK SHARP DOHME İLAÇLARI LİMİTED ŞİRKETİ |
| 3/14/2024 | 300215000000 | IMMUNITY PRODUCTS DOSED OR PACKAGED/PREPARED FOR RETAIL SALE (THEY ARE NOT ONE OF THE MEDICAL DIAGNOSTIC KITS WITHIN THE SCOPE OF MEDICAL DIAGNOSTIC DEVICES. THEY ARE FOR RESEARCH PURPOSES IN THE GENERAL LABORATORY AND ARE NOT PERFORMED IN 2024/16 AND 202 | 2 | UNIT | 127 | N/A | BECKMAN COULTER BİYOMEDİKAL ÜRÜNLER SANAYİ VE TİCARET LİMİTED ŞİRKETİ |
| 3/5/2024 | 300215000000 | IMMUNITY PRODUCT (LABELLED CARTON CONTAINING 16 VIALS OF SACITUZUMAB GOVITECAN (IMMU 132) LYOPHILIZE+D 200 MG/50ML) (TO BE USED IN CLINICAL RESEARCH) | 50 | SET | 237208 | N/A | SMO TU LOJİSTİK VE AMBALAJ SANAYİ VE TİCARET LİMİTED ŞİRKETİ |
| 3/20/2024 | 300215000000 | IMMUNITY PRODUCT (LABELED 1X CARTON CONTAINING SACITUZUMAB GOVITECAN LYOPHILIZED POWDER FOR SOLUTION+ FOR INFUSION 200 MG VIAL) (TO BE USED IN CLINICAL RESEARCH) | 225 | SET | 67619 | N/A | SMO TU LOJİSTİK VE AMBALAJ SANAYİ VE TİCARET LİMİTED ŞİRKETİ |
| 3/22/2024 | 300215000000 | LABELLED 1X TAK 573 10 MG/ML 50 MG FOR CLINICAL RESEARCH PURPOSES (NOT IN THE SCOPE OF 2024/16 -19 NOTIFICATION.) | 5 | UNIT | 367 | N/A | ŞULE MENE SAĞLIK ARAŞTIRMA EĞİTİM DANIŞMANLIK BİLİŞİM SANAYİ TİCARET ANONİM ŞİRKETİ |